CONMED (CNMD) vs Integer (ITGR)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Integer (ITGR) has outperformed CONMED (CNMD) over the past year, gaining 22.0% versus a loss of 3.6%. Over five years, ITGR leads with a +41.8% price change compared with -68.9% for CNMD. Integer is the larger company by market cap ($4.30 billion vs $1.35 billion), about 3.2 times the size.
On valuation, CONMED trades at a lower forward P/E (9.5x vs 18.4x for Integer). CONMED pays a dividend yielding 0.44%, while Integer does not currently pay one.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNMD | ITGR |
|---|---|---|
| Share price | $45.20 | $126.58 |
| Market cap | $1.35B | $4.30B |
| 1-day change | +2.19% | -0.01% |
| YTD return | +8.94% | +61.41% |
| 1-year return | -3.64% | +22.05% |
| 5-year return | -68.86% | +41.79% |
| P/E ratio (TTM) | 24.43 | 34.58 |
| Forward P/E | 9.45 | 18.43 |
| EPS (TTM) | $1.85 | $3.66 |
| Dividend yield | 0.44% | 0.00% |
| Annual dividend | $0.20 | $0.00 |
| Revenue (latest FY) | — | $1.85B |
| Revenue growth (YoY) | — | +7.98% |
| Net income (latest FY) | — | $102.81M |
| Gross margin | — | 26.99% |
| Operating margin | — | 11.94% |
| Net margin | — | 5.55% |
| 52-week high | $53.66 | $126.80 |
| 52-week low | $31.44 | $62.00 |
| Distance from 52-week high | -15.77% | -0.17% |
| Analyst consensus | none | none |
| Avg. price target upside | +0.66% | -3.78% |
| Average volume | 493.66K | 981.56K |
| Shares outstanding | 29.95M | 34.00M |
| Employees | 3,900 | 11,000 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Integer is about 3.2 times larger than CONMED by market value ($4.30B vs $1.35B).
- ITGR has outperformed CNMD by 25.7 percentage points over the past year.
- Integer trades at a higher earnings multiple (34.6x vs 24.4x trailing P/E).
About CONMED
CNMD stock →CONMED Corporation, a medical technology company, develops, manufactures, and sells devices and equipment for surgical procedures. The company offers orthopedic surgery products, including BioBrace, TruShot with Y-Knot All-In-One Soft Tissue Fixation System, Y-knot All-Suture Anchors, and Agro Knotless Suture Anchors, which provide clinical solutions to orthopedic surgeons for the augmentation and repair of soft tissue injuries, as well as supporting products include powered resection instruments , fluid management, and visualization systems and the related single-use products that enable surgeons to perform minimally invasive sports medicine surgeries.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 3,900 employees
About Integer
ITGR stock →Integer Holdings Corporation operates as a medical device contract development and manufacturing company in the United States, Costa Rica, Puerto Rico, Ireland, and internationally. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 11,000 employees
CNMD vs ITGR FAQ
Which is bigger, CONMED or Integer?
Integer (ITGR) is larger, with a market capitalization of $4.30B compared with $1.35B for CONMED (CNMD).
Which stock has performed better over the past year, CNMD or ITGR?
ITGR returned +22.05% over the past 12 months, compared with -3.64% for CNMD (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CNMD or ITGR?
CNMD has the lower trailing P/E at 24.4, versus 34.6 for ITGR. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, CONMED or Integer?
CONMED pays a dividend yielding 0.44%, while Integer does not currently pay a regular dividend.
Are CONMED and Integer in the same industry?
Yes. Both are classified in the Biotechnology: Electromedical & Electrotherapeutic Apparatus industry within the Health Care sector.